Egashira T, Nagai T, Kimba Y, Takano R, Yamanaka Y
Department of Pharmacology, Medical College of Oita, Japan.
Jpn J Pharmacol. 1989 Oct;51(2):211-8. doi: 10.1254/jjp.51.211.
The effects of bifemelane hydrochloride (BF) upon various cholinergic markers, muscarinic receptors, acetylcholinesterase (AChE) and choline acetyltransferase (CAT), in the aged rat brain were examined. Marked reduction of the density of muscarinic receptors (Bmax) as well as AChE and CAT activity concomitant with aging was observed. Administration of BF in daily doses of 10 mg/kg for 4 weeks to aged rats significantly decreased the apparent dissociation constant (Kd) for QNB in muscarinic receptors in the forebrain, but did not affect the value of Bmax. CAT activity also increased significantly compared with that of control aged rats, but administration of BF did not alter AChE activity. These results indicate that long-term treatment with BF enhances the affinity of muscarinic receptors for QNB as well as CAT activity and that BF may have therapeutic application in the treatment of CNS cholinergic dysfunctions.
研究了盐酸比芬美兰(BF)对老年大鼠脑内各种胆碱能标志物、毒蕈碱受体、乙酰胆碱酯酶(AChE)和胆碱乙酰转移酶(CAT)的影响。观察到随着衰老,毒蕈碱受体密度(Bmax)以及AChE和CAT活性显著降低。给老年大鼠每日按10mg/kg剂量给药BF 4周,可显著降低前脑毒蕈碱受体中QNB的表观解离常数(Kd),但不影响Bmax值。与对照老年大鼠相比,CAT活性也显著增加,但给予BF并未改变AChE活性。这些结果表明,长期用BF治疗可增强毒蕈碱受体对QNB的亲和力以及CAT活性,且BF可能在中枢神经系统胆碱能功能障碍的治疗中有治疗应用价值。